chlordiazepoxide hcl and clidinium bromide

Generic: chlordiazepoxide hcl and clidinium bromide

Labeler: micro labs limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name chlordiazepoxide hcl and clidinium bromide
Generic Name chlordiazepoxide hcl and clidinium bromide
Labeler micro labs limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

chlordiazepoxide hydrochloride 5 mg/1, clidinium bromide 2.5 mg/1

Manufacturer
Micro Labs Limited

Identifiers & Regulatory

Product NDC 42571-381
Product ID 42571-381_fa3753a6-a410-6ae8-e053-6394a90a0106
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215835
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2022-10-01

Pharmacologic Class

Classes
anticholinergic [epc] benzodiazepine [epc] benzodiazepines [cs] cholinergic antagonists [moa] decreased parasympathetic acetylcholine activity [pe] digestive/gi system activity alteration [pe] gi motility alteration [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42571381
Hyphenated Format 42571-381

Supplemental Identifiers

RxCUI
889614
UPC
0342571381011
UNII
MFM6K1XWDK 91ZQW5JF1Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chlordiazepoxide hcl and clidinium bromide (source: ndc)
Generic Name chlordiazepoxide hcl and clidinium bromide (source: ndc)
Application Number ANDA215835 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
  • 2.5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (42571-381-01)
source: ndc

Packages (1)

42571-381-01 100 CAPSULE in 1 BOTTLE (42571-381-01)

Ingredients (2)

chlordiazepoxide hydrochloride (5 mg/1) clidinium bromide (2.5 mg/1)

Linked Drug Pages (1)

CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fa3753a6-a410-6ae8-e053-6394a90a0106", "openfda": {"upc": ["0342571381011"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["cd820fcb-b6a8-43f4-a6d9-f94546d380c8"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (42571-381-01)", "package_ndc": "42571-381-01", "marketing_start_date": "20221001"}], "brand_name": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "product_id": "42571-381_fa3753a6-a410-6ae8-e053-6394a90a0106", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "42571-381", "dea_schedule": "CIV", "generic_name": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA215835", "marketing_category": "ANDA", "marketing_start_date": "20221001", "listing_expiration_date": "20261231"}